Daniel Sargent
Affiliations: | History | University of California, Berkeley, Berkeley, CA, United States |
Area:
America since 1607Google:
"Daniel Sargent"Parents
Sign in to add mentor| Akira Iriye | grad student | 2008 | Harvard | |
| (From internationalism to globalism: The United States and the transformation of international politics in the 1970s) | ||||
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Renfro LA, Sargent DJ. (2016) Findings from the Adjuvant Colon Cancer End Points (ACCENT) Collaborative Group: the power of pooled individual patient data from multiple clinical trials. Chinese Clinical Oncology. 5: 80 |
| Althammer S, Steele K, Rebelatto M, et al. (2016) 31st Annual Meeting and Associated Programs of the Society for Immunotherapy of Cancer (SITC 2016): late breaking abstracts Journal For Immunotherapy of Cancer. 4 |
| Renfro LA, Shi Q, Sargent DJ. (2013) Mining the ACCENT database: a review and update. Chinese Clinical Oncology. 2: 18 |
| Oba K, Paoletti X, Alberts S, et al. (2013) Disease-free survival as a surrogate for overall survival in adjuvant trials of gastric cancer: a meta-analysis. Journal of the National Cancer Institute. 105: 1600-7 |
| André T, Iveson T, Labianca R, et al. (2013) The IDEA (International Duration Evaluation of Adjuvant Chemotherapy) Collaboration: Prospective Combined Analysis of Phase III Trials Investigating Duration of Adjuvant Therapy with the FOLFOX (FOLFOX4 or Modified FOLFOX6) or XELOX (3 versus 6 months) Regimen for Patients with Stage III Colon Cancer: Trial Design and Current Status. Current Colorectal Cancer Reports. 9: 261-269 |
| Sanoff HK, Carpenter WR, Martin CF, et al. (2012) Comparative effectiveness of oxaliplatin vs non-oxaliplatin-containing adjuvant chemotherapy for stage III colon cancer. Journal of the National Cancer Institute. 104: 211-27 |
| Yothers G, Sargent DJ, Wolmark N, et al. (2011) Outcomes among black patients with stage II and III colon cancer receiving chemotherapy: an analysis of ACCENT adjuvant trials. Journal of the National Cancer Institute. 103: 1498-506 |
| Goldberg RM, Sargent DJ, McLeod H. (2010) Leveraging learning from a phase III colorectal cancer clinical trial: outcomes, methodology, meta-analysis and pharmacogenetics Transactions of the American Clinical and Climatological Association. 121 |
| Goldberg RM, Sargent DJ, Morton RF, et al. (2006) Randomized controlled trial of reduced-dose bolus fluorouracil plus leucovorin and irinotecan or infused fluorouracil plus leucovorin and oxaliplatin in patients with previously untreated metastatic colorectal cancer: a North American Intergroup Trial. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 24: 3347-53 |